slotkoers
Taipei Exchange
00:00:00 15-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
66,7
TWD
|
+1,21%
|
|
+1,68%
|
+14,80%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.310
|
1.925
|
1.920
|
1.880
|
2.063
|
2.737
|
Bedrijfswaarde
1 |
896,4
|
1.542
|
1.544
|
1.511
|
1.640
|
1.875
|
K/w-verhouding
|
53,9
x
|
290
x
|
151
x
|
70,7
x
|
54,9
x
|
35
x
|
Dividendrendement
|
1,06%
|
0,32%
|
0,45%
|
1,23%
|
1,59%
|
1,22%
|
Marktkapitalisatie/omzet
|
1,7
x
|
2,48
x
|
2,38
x
|
2,04
x
|
2,1
x
|
2,43
x
|
Bedrijfswaarde/omzet
|
1,16
x
|
1,99
x
|
1,91
x
|
1,64
x
|
1,67
x
|
1,66
x
|
Bedrijfswaarde/EBITDA
|
14,7
x
|
44,4
x
|
66
x
|
27,4
x
|
19,7
x
|
17,2
x
|
Bedrijfswaarde/FCF
|
-2.991
x
|
71,9
x
|
37,4
x
|
-151
x
|
26,6
x
|
26,7
x
|
FCF Yield
|
-0,03%
|
1,39%
|
2,67%
|
-0,66%
|
3,76%
|
3,74%
|
Price to Book
|
1,15
x
|
1,8
x
|
1,79
x
|
1,72
x
|
1,91
x
|
2,31
x
|
Aantal aandelen (in duizenden)
|
49.627
|
47.483
|
47.513
|
47.475
|
46.993
|
47.117
|
Referentieprijs
2 |
26,40
|
40,55
|
40,40
|
39,60
|
43,90
|
58,10
|
Datum van publicatie
|
29/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
31/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
770,6
|
775,6
|
806,6
|
921,4
|
980,4
|
1.127
|
EBITDA
1 |
60,96
|
34,7
|
23,41
|
55,17
|
83,41
|
109,1
|
Bedrijfsresultaat (EBIT)
1 |
34,23
|
8,19
|
-3,808
|
31,21
|
56,82
|
84,69
|
Operationele Marge
|
4,44%
|
1,06%
|
-0,47%
|
3,39%
|
5,8%
|
7,51%
|
Resultaat voor belastingen (EBT)
1 |
45,79
|
25,76
|
6,422
|
41,19
|
70,46
|
107,1
|
Nettowinst (verlies)
1 |
24,23
|
6,803
|
12,74
|
26,62
|
37,97
|
78,4
|
Nettomarge
|
3,14%
|
0,88%
|
1,58%
|
2,89%
|
3,87%
|
6,95%
|
WPA
2 |
0,4900
|
0,1400
|
0,2682
|
0,5600
|
0,8000
|
1,660
|
Free Cash Flow
1 |
-0,2998
|
21,44
|
41,31
|
-10,01
|
61,69
|
70,21
|
FCF-marge
|
-0,04%
|
2,76%
|
5,12%
|
-1,09%
|
6,29%
|
6,23%
|
Kasstroomconversie (ebitda)
|
-
|
61,78%
|
176,51%
|
-
|
73,96%
|
64,38%
|
Kasstroomconversie (nettowinst)
|
-
|
315,14%
|
324,26%
|
-
|
162,47%
|
89,56%
|
Dividend per aandeel
2 |
0,2800
|
0,1300
|
0,1800
|
0,4858
|
0,6965
|
0,7100
|
Datum van publicatie
|
29/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
31/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
414
|
384
|
375
|
369
|
423
|
862
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0,3
|
21,4
|
41,3
|
-10
|
61,7
|
70,2
|
ROE (netto-inkomsten/eigen vermogen)
|
2,75%
|
1,57%
|
0,1%
|
2,51%
|
4,06%
|
5,34%
|
ROA (netto-inkomsten/totale activa)
|
1,19%
|
0,29%
|
-0,14%
|
1,11%
|
1,96%
|
2,53%
|
Totale activa
1 |
2.044
|
2.356
|
-9.361
|
2.401
|
1.937
|
3.101
|
Nettoactief per aandeel
2 |
22,90
|
22,50
|
22,60
|
23,00
|
23,00
|
25,10
|
Cashflow per aandeel
2 |
2,000
|
1,660
|
2,690
|
2,550
|
3,440
|
5,040
|
Capex
1 |
16,6
|
11,6
|
26,8
|
10,2
|
28,9
|
20
|
Capex/omzet
|
2,16%
|
1,5%
|
3,33%
|
1,1%
|
2,95%
|
1,78%
|
Datum van publicatie
|
29/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
31/03/23
|
19/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +14,80% | 98,16 mln. | | +29,77% | 49,46 mld. | | +1,00% | 42,58 mld. | | +49,39% | 42,49 mld. | | -5,26% | 29,09 mld. | | +13,68% | 26,61 mld. | | -22,99% | 18,64 mld. | | +8,22% | 13,16 mld. | | +32,41% | 12,55 mld. | | +24,01% | 12,1 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|